ENDRA Life Sciences Inc. (NASDAQ: NDRA) ("ENDRA" or the "Company"), a pioneer in biomarker imaging technologies for the early ...

This multi-target blood test "offers the potential for improved patient outcomes through earlier HCC detection," John said ...

Recognizing early liver disease signs is crucial as many conditions develop silently. Persistent fatigue, jaundice, abdominal swelling, confusion, fre ...

Dr. Christopher Kelly: A biomarker is a biological substance that can be objectively measured and tracked to provide ...

Detailed price information for Exact Sciences Cor (EXAS-Q) from The Globe and Mail including charting and trades.

The retrospective phase 2b study, which explored the use of various non-invasive tests (NITs) to assess response to semaglutide, adds to growing evidence that the drug not only improves metabolic ...

Liver fibrosis is a growing global concern, driven by chronic conditions like hepatitis, obesity, and alcohol use. This progressive liver disease, marked by scar tissue buildup, can advance to ...

At the American Association for the Study of Liver Diseases (AASLD) annual meeting, a session highlighted new guidance on ...

Think deep space imaging requires expensive gear? Think again! In this video, we explore how to capture stunning deep space ...

Recent Indian studies estimate that approximately 101 million adults in India are living with diabetes, with an additional ...

The therapeutic landscape for hepatocellular carcinoma (HCC) has been revolutionized by the advent of molecular targeted therapies and immune ...

Think one soda now and then is harmless? Think again. New data presented at United European Gastroenterology (UEG) Week shows ...